Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SAS plans pharma best practices forum
PhUSE is being billed as a “knowledge exchange” event for SAS software professionals. Leading pharmaceutical firms like AstraZeneca, GlaxoSmithKline, Pfizer and Roche are managing the agenda. PhUSE is
PhUSE is being billed as a “knowledge exchange” event for SAS software professionals. Leading pharmaceutical firms like AstraZeneca, GlaxoSmithKline, Pfizer and Roche are managing the agenda. PhUSE is
The study represents the first part of Peregrine’s FDA approved product registration clinical trial for Cotara. The trial will enroll patients at four New Approaches to Brain Tumor
The declaration was made in a resolution adopted at the end of the Regional Committee for Africa’s fifty-fifth session in Maputo, Mozambique. The resolution urges Member States in
If approved for this new indication, the company says Femara will become the only breast cancer treatment approved in the US to significantly reduce the risk of recurrence
None of these gene variants have previously been associated with myocardial infarction (MI), and they could lead to the identification of new coronary heart disease (CHD) mechanisms. Celera
St Paul’s agreement includes the distribution of Ferrazone in Vietnam, Cambodia and Laos with a potential market of over 100 million people. Ferrazone is Akzo Nobel’s brand name
The phase II study results that showed a reduction in mortality in eritoran-treated patients versus placebo. The company plans to initiate a phase III clinical program after consulting
Although research on humans is still a distant possibility, the scientists believe their discovery may hold promise in the treatment of a variety of illnesses linked to memory.
Awarded by the National Human Genome Research Institute (NHGRI), one of 27 institutes and centers at the National Institutes of Health (NIH), the NHGRI “Near-Term Development for Genome
Researchers from Leiden University Medical Center in the Netherlands used magnetic resonance imaging (MRI) to examine the brains of elderly patients with and without dementia related to Alzheimer’s